Wenjia Yang

6PUBLICATIONS
10CO-AUTHORS
Information systems development methodologies and practiceCancer geneticsEpidemiological methodsMolecular targetsMedical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 27, 2025
Control of the cardiovascular risk factors in patients with type 2 diabetes mellitus in China in 2023-2024.

Wenjia Yang, Xiaoling Cai, Qiuhe Ji

|Jul 09, 2025
Glucagon-like peptide-1 receptor agonist treatment associated weight fluctuation and influencing factors in patients with overweight or obesity.

Jingxuan Wang, Chu Lin, Xiaoling Cai

|Dec 24, 2024
Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials.

Zonglin Li, Chu Lin, Xiaoling Cai

|Nov 21, 2024
One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA.

Mengqing Zhang, Chu Lin, Xiaoling Cai

|Oct 21, 2024
Characterizing body composition modifying effects of a glucagon-like peptide 1 receptor-based agonist: A meta-analysis.

Ruoyang Jiao, Chu Lin, Xiaoling Cai

|Feb 12, 2024
Weight reduction and the risk of gallbladder and biliary disease: A systematic review and meta-analysis of randomized clinical trials.

Wenjia Yang, Han Wu, Xiaoling Cai

Pageof 1

Frequent Collaborators

6 joint publications

Xiaoling Cai

5 joint publications

Chu Lin

5 joint publications

Linong Ji

2 joint publications

Zonglin Li